Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Overview: Alopecia • Causes of hair loss • Hair loss: Symptoms and treatment PART 06: Pipeline portfolio PART 07: Market landscape • Market overview • Five forces analysis PART 08: Key buying criteria PART 09: Market segmentation by ROA • Global topical alopecia drugs market • Global oral alopecia drugs market • Global injectable alopecia drugs market PART 10: Market segmentation by gender PART 11: Geographical segmentation • Alopecia drugs market in Americas • Alopecia drugs market in EMEA • Alopecia drugs market in APAC PART 12: Market drivers • Lifestyle changes • Popularity of off-label and OTC drugs • High uptake of approved therapies PART 13: Impact of drivers PART 14: Market challenges • Poor patient adherence • Preference for alternative therapies • Limited approved therapies PART 15: Impact of drivers and challenges PART 16: Market trends • Focus on regenerative medicines • Emergence of laser technology and PRP therapy • Launch of new products PART 17: Vendor landscape • Competitive scenario • Other prominent vendors PART 18: Key vendor analysis • GlaxoSmithKline • Johnson & Johnson • Merck PART 19: Appendix • List of abbreviations PART 20: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Major types of alopecia Exhibit 03: Major factors responsible for hair loss Exhibit 04: Symptoms and treatment of hair loss Exhibit 05: Pipeline analysis of major companies for global alopecia drugs market Exhibit 06: Share of pipeline molecules in global alopecia drugs market Exhibit 07: Pipeline analysis of major companies for global alopecia drugs market Exhibit 08: Market snapshot: Global alopecia drugs market Exhibit 09: Incidence rates of alopecia areata 2015 (in percentage of population) Exhibit 10: Possibility of hair loss (men) grows with age 2015 Exhibit 11: Distribution of population aged 60 years and over (millions) Exhibit 12: Factors influencing the global alopecia drugs market 2015 Exhibit 13: Global alopecia drugs market snapshot: Developed and emerging markets 2015 Exhibit 14: Global alopecia drugs market 2015-2020 ($ billions) Exhibit 15: Hair loss treatment cost Exhibit 16: Key strategies in global alopecia drugs market Exhibit 17: Five forces analysis Exhibit 18: Key buying criteria for alopecia drugs market Exhibit 19: Key buying criteria for global alopecia drugs market 2015 Exhibit 20: Impact of key customer segments on global alopecia drugs market 2015 Exhibit 21: Global alopecia drugs segmentation market by route of administration Exhibit 22: Global alopecia drugs market: Segmentation by type 2015-2020 Exhibit 23: Global alopecia drugs market segmentation: Growth cycle analysis Exhibit 24: Global topical alopecia drugs market 2015-2020 ($ billions) Exhibit 25: Global oral alopecia drugs market 2015-2020 ($ millions) Exhibit 26: Global injectable alopecia drugs market 2015-2020 ($ millions) Exhibit 27: Snapshot of global alopecia drugs market by gender Exhibit 28: Willingness toward treatment among individuals affected with hair loss Exhibit 29: Snapshot of global alopecia drugs market by geography Exhibit 30: Global alopecia drugs market: Country analysis based on revenue and growth rate Exhibit 31: Global alopecia drugs market segmentation by geography 2015-2020 ($ millions) Exhibit 32: Overview of alopecia drugs market in Americas Exhibit 33: Prevalence of alopecia areata in Americas 2015 (millions) Exhibit 34: Alopecia drugs market in Americas 2015-2020 ($ billions) Exhibit 35: Overview of alopecia drugs market in EMEA Exhibit 36: Alopecia drugs market in EMEA 2015-2020 ($ millions) Exhibit 37: Prevalence of alopecia areata in EMEA 2015 (millions) Exhibit 38: Overview of alopecia drugs market in APAC Exhibit 39: Alopecia drugs market in APAC 2015-2020 ($ millions) Exhibit 40: Prevalence of alopecia areata in APAC 2015 (millions) Exhibit 41: Impact of alcohol on hair loss Exhibit 42: Impact of stress on hair loss Exhibit 43: Off-label usage: Tagamet (cimetidine) for the treatment of alopecia Exhibit 44: Few of the popular OTC drugs used for the treatment of alopecia Exhibit 45: Market scenario of leading Alopecia drugs: Present and future Exhibit 46: Impact of drivers Exhibit 47: Side effects associated with approved therapies Exhibit 48: Hair loss surgeries performed in 2015 Exhibit 49: Number of hair restoration procedures worldwide 2015 Exhibit 50: Impact of drivers and challenges Exhibit 51: Overview of alopecia in regenerative medicine market Exhibit 52: Variety of growth factors released from PRP therapy Exhibit 53: List of pipeline candidates for alopecia treatment Exhibit 54: Competitive structure analysis of global alopecia drugs market 2015 Exhibit 55: Performance/initiatives of existing and upcoming vendors in global alopecia drugs market Exhibit 56: Geographical presence of key vendors Exhibit 57: GlaxoSmithKline: Profile Exhibit 58: GlaxoSmithKline: Strength assessment Exhibit 59: GlaxoSmithKline: Strategy assessment Exhibit 60: GlaxoSmithKline: Opportunity assessment Exhibit 61: Johnson & Johnson: Strength assessment Exhibit 62: Johnson & Johnson: Strategy assessment Exhibit 63: Johnson & Johnson: Opportunity assessment Exhibit 64: Merck: Strength assessment Exhibit 65: Merck: Strategy assessment Exhibit 66: Merck: Opportunity assessment

GlaxoSmithKline, Johnson & Johnson, Merck, Aclaris Therapeutics, Actelion Pharmaceuticals, Almirall, AndroScience, Anterios, Aqua Pharmaceuticals, Astellas Pharma, Bayer HealthCare, BERG Health, BiologicsMD, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, Concert Pharmaceuticals, Cosmo Pharmaceuticals, Dermira, Elorac, F. Hoffmann-La Roche, Foamix, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Hyundai Pharm, Incyte, Kasiak Research, Kythera Biopharmaceuticals, Mylan, NovaLead Pharma, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Polichem, Promius Pharma, Ranbaxy Laboratories, Reckitt Benckiser, Regience, Samumed, RepliCel, Skinvisible Pharmaceuticals, Teva Pharmaceutical, Versapharm, XBiotech.